Biofrontera Statistics

Total Valuation

Biofrontera has a market cap or net worth of $5.85 million. The enterprise value is $8.81 million.

Market Cap	5.85M
Enterprise Value	8.81M

Important Dates

The last earnings date was Thursday, May 15, 2025, after market close.

Earnings Date	May 15, 2025
Ex-Dividend Date	n/a

Share Statistics

Biofrontera has 8.87 million shares outstanding. The number of shares has increased by 222.35% in one year.

Current Share Class	8.87M
Shares Outstanding	8.87M
Shares Change (YoY)	+222.35%
Shares Change (QoQ)	+17.29%
Owned by Insiders (%)	9.83%
Owned by Institutions (%)	19.55%
Float	6.53M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.12
Forward PS	0.16
PB Ratio	12.68
P/TBV Ratio	13.10
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.23
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.40, with a Debt / Equity ratio of 10.37.

Current Ratio	1.40
Quick Ratio	0.53
Debt / Equity	10.37
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-20.24

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-49.47%
Return on Invested Capital (ROIC)	-284.71%
Return on Capital Employed (ROCE)	-289.39%
Revenue Per Employee	$408,570
Profits Per Employee	-$123,925
Employee Count	93
Asset Turnover	1.85
Inventory Turnover	2.64

Taxes

In the past 12 months, Biofrontera has paid $20,000 in taxes.

Income Tax	20,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -38.41% in the last 52 weeks. The beta is 0.38, so Biofrontera's price volatility has been lower than the market average.

Beta (5Y)	0.38
52-Week Price Change	-38.41%
50-Day Moving Average	0.80
200-Day Moving Average	0.99
Relative Strength Index (RSI)	38.96
Average Volume (20 Days)	175,594

Short Selling Information

The latest short interest is 37,741, so 0.43% of the outstanding shares have been sold short.

Short Interest	37,741
Short Previous Month	52,880
Short % of Shares Out	0.43%
Short % of Float	0.58%
Short Ratio (days to cover)	0.46

Income Statement

In the last 12 months, Biofrontera had revenue of $38.00 million and -$11.53 million in losses. Loss per share was -$1.69.

Revenue	38.00M
Gross Profit	20.24M
Operating Income	-16.29M
Pretax Income	-23.08M
Net Income	-11.53M
EBITDA	-15.89M
EBIT	-16.29M
Loss Per Share	-$1.69

Full Income Statement

Balance Sheet

The company has $1.79 million in cash and $4.86 million in debt, giving a net cash position of -$3.07 million or -$0.35 per share.

Cash & Cash Equivalents	1.79M
Total Debt	4.86M
Net Cash	-3.07M
Net Cash Per Share	-$0.35
Equity (Book Value)	469,000
Book Value Per Share	0.05
Working Capital	4.37M

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 53.26%, with operating and profit margins of -42.87% and -30.33%.

Gross Margin	53.26%
Operating Margin	-42.87%
Pretax Margin	-30.28%
Profit Margin	-30.33%
EBITDA Margin	-41.82%
EBIT Margin	-42.87%
FCF Margin	n/a

Dividends & Yields

Biofrontera does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-222.35%
Shareholder Yield	-222.35%
Earnings Yield	-200.80%
FCF Yield	n/a

Analyst Forecast

The average price target for Biofrontera is $2.75, which is 317.30% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$2.75
Price Target Difference	317.30%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	25.32%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on July 5, 2023. It was a reverse split with a ratio of 0.05:1.

Last Split Date	Jul 5, 2023
Split Type	Reverse
Split Ratio	0.05:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2